Our research is focused on three primary areas:

Epidemiology of cerebrovascular disease in HIV infection: We are studying the role of traditional and novel stroke risk factors in HIV-associated cerebrovascular disease, with an eye toward developing preventive and therapeutic strategies to improve cerebrovascular and cognitive health of persons living with HIV.

Sex and race disparities in cerebrovascular risk in HIV infection: Our research has characterized sex and race differences in cerebrovascular risk and its contribution to cognitive function in persons living with HIV. We are working to identify and address mechanisms driving these observed disparities.

Treatment strategies for CNS tuberculosis: Our work aims to improve neurologic and functional outcomes for survivors of tuberculous meningitis and other forms of tuberculosis of the nervous system.

 

 

Click on a study below to learn more about our current work:

The Epic Neuro sub-study

The Epic Neuro sub-study: Stress and stroke risk in persons living with HIV

Learn more

Mind over risk

Mind over risk: A pilot trial of a mindfulness based stress reduction intervention to reduce cerebrovascular risk

Learn more

ALTER: Adjunctive Linezolid for the Treatment of tubERuclous meningitis

Learn more

CHASM: Cerebrovascular mechanisms of HIV-ASsociated cognitive iMpairment in China

CHASM: Cerebrovascular mechanisms of HIV-ASsociated cognitive iMpairment in China

Learn more

TESA: A phase II trial of tesamorelin for cognition in aging HIV-infected persons

TESA: A phase II trial of tesamorelin for cognition in aging persons living with HIV

Learn more

IMAGINE-TBM (A5384): Improved Management with Antimicrobial aGents Isoniazid rifampiciN LinEzolid for TBM

IMAGINE-TBM (A5384):  Improved Management with Antimicrobial aGents Isoniazid rifampiciN LinEzolid for TBM

Learn more

NeuroAIDS Research in Nigeria

NeuroAIDS Research in Nigeria: Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria

Learn more

SEMANTICCS

SEMANTICCS: SEx differences in MechANisms of impaired cogniTIon in people with HIV infection from the CCS

Learn more

SEMANTICCS

Lyme Clinical Trials Network: Investigating therapies to improve outcomes in Lyme disease 

Learn more

 

Novel Biomarker Technology for Cancer Diagnostics Developed | Technology  Networks

Novel Diagnostic for NCC: Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients

Learn more